Phase I Study Of Proteasome Inhibitor Bortezomib (B) Concurrent With Re-Irradiation Therapy (Re-Rt) For Recurrent Squamous Cell Carcinoma Of The Head And Neck (Scchn).
JOURNAL OF CLINICAL ONCOLOGY(2010)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要